SELLAS
is a New York-based late-stage clinical biopharmaceutical company that researches and develops novel therapies for the treatment of cancer... Read moreSELLAS
is a New York-based late-stage clinical biopharmaceutical company that researches and develops novel therapies for the treatment of cancer... Read more
News
May 14, 2026
Benzinga
SELLAS: SELLAS Life Sciences to Participate in Upcoming Investor Conferences
May 13, 2026
Benzinga
SELLAS: SELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline Progresses
Apr 22, 2026
Seeking Alpha
SELLAS: Sellas Life Sciences: Behind The Big Surge
Mar 22, 2026
Yahoo
SELLAS: Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run
Mar 20, 2026
Owler
SELLAS Life Sciences Group, Inc.: SELLAS's employee count changed from 15 in Mar 2025 to 13 in Mar 2026
Mar 20, 2026
Nasdaq
SELLAS: SELLAS FY25 Net Loss Narrows; Approaching Final Analysis Of The Phase 3 REGAL Trial For GPS In AML
Mar 19, 2026
GlobeNewswire
Press Release: SELLAS : SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
Mar 17, 2026
GlobeNewswire
Press Release: SELLAS : SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
Mar 12, 2026
GlobeNewswire
Press Release: SELLAS : SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
Mar 04, 2026
Benzinga
SELLAS: What's Going With SELLAS Life Sciences Stock On Wednesday
SELLAS Competitors
1
2
3
4
5
6
7
8
9
10